UK reviewing Palantir's NHS contract amid pressure to use break clause

Britain is reviewing a major contract with American firm Palantir for the National Health Service. The government must decide by early 2027 whether to continue the deal. Concerns about patient data privacy and reliance on a foreign supplier are central to the review. Parliamentarians have urged the government to end the contract, citing risks.